Previous close | 56.35 |
Open | 56.35 |
Bid | 64.00 |
Ask | 67.25 |
Strike | 125.00 |
Expiry date | 2024-01-19 |
Day's range | 56.35 - 56.35 |
Contract range | N/A |
Volume | |
Open interest | 104 |
Yahoo Finance health reporter Anjalee Khemlani outlines the events surrounding the FDA's ban on Juul products and e-cigarettes, as well as Pfizer's Paxlovid COVID-19 treatment pill receiving an Emergency Use Authorization from the FDA.
Yahoo Finance's health care reporter Anjalee Khemlani breaks down the latest health news, including risks from the BA.5 and BA.4 COVID subvariants and giant African snails that have been spotted in Florida.
Pfizer (NYSE: PFE) is already the leader in the coronavirus vaccine space. Rival Moderna (NASDAQ: MRNA) has a significant position in the market. Latecomer Novavax (NASDAQ: NVAX) could also take market share in the months to come.